美国鼻科学会专家实践声明:鼻窦手术术后疼痛管理与阿片类药物使用
该专家实践声明由美国鼻科学会按既定方法与审批流程制定,围绕术前宣教、局部麻醉、术后阿片类与非阿片类药物镇痛、非甾体抗炎药与出血、加巴喷丁镇痛等主题,采用改良Delphi法形成6条声明,其中5条达成共识、1条未达成共识,并汇总了相应证据与未来需求。
要点
- 围绕术前宣教、局部麻醉及术后阿片类与非阿片类镇痛等6个主题形成声明。
- 经改良Delphi法形成6条声明,5条达成共识、1条未达成共识。
- 声明附有证据总结及对未来研究需求的评估。
核心结论
- 该声明就鼻窦手术术后疼痛管理提出6条声明,5条达成共识、1条未达成共识,并附证据总结与未来需求评估。
研究设计与样本
- 美国鼻科学会专家实践声明,按既定推荐方法与审批流程制定,采用改良Delphi法形成6条声明。
主要发现
- 6条声明中5条达成共识、1条未达成共识,覆盖术前宣教、局部麻醉、术后阿片类与非阿片类药物镇痛、非甾体抗炎药与出血、加巴喷丁镇痛等主题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The goal of this American Rhinologic Society expert practice statement (EPS) is to provide clinically applicable, evidence-based recommendations regarding pain management in sinonasal surgery. This EPS was developed following the recommended methodology and approval process as previously outlined. The topics of interest included preoperative counseling, local anesthesia, use of opioids for postoperative pain, use of nonopioid medication for postoperative pain, nonsteroidal anti-inflammatory drugs and bleeding, and use of gabapentin for pain control. Following a modified Delphi approach, 6 statements were developed, 5 of which reached consensus and 1 that did not. These statements and accompanying evidence are summarized along with an assessment of future needs.
引用
- Lee JT, Levine CG, Overdevest JB, et al. American Rhinologic Society expert practice statement: Postoperative pain management and opioid use after sinonasal surgery. Int Forum Allergy Rhinol. 2021. PMID: 34251080. doi:10.1002/alr.22847
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。